Article
|
Open Access
Featured
-
-
Article |
Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer
- Yiwen Zhang
- , Konrad H. Stopsack
- & Edward Giovannucci
-
Comment
| Open AccessShifting the paradigm in the management of early prostate cancer
- Vincent Gnanapragasam
-
Article
| Open AccessCapivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer
- Cath Eberlein
- , Stuart C. Williamson
- & Simon T. Barry
-
Article |
A prospective study of birth weight and prostate cancer risk and mortality in the Health Professionals Follow-up Study
- Qinran Liu
- , Yiwen Zhang
- & Siobhan Sutcliffe
-
Article
| Open AccessTumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas
- Dorottya Moldvai
- , Dániel Sztankovics
- & Anna Sebestyén
-
Article
| Open AccessSynergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer
- Lu Zhang
- , Ruiyun Zhang
- & Jinhai Fan
-
Article |
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
- Benoit Blanchet
- , Alexandre Xu-Vuilard
- & Yann-Alexandre Vano
-
Article |
Tumor-associated neutrophils suppress CD8+ T cell immunity in urothelial bladder carcinoma through the COX-2/PGE2/IDO1 Axis
- Yi Ouyang
- , Wenlong Zhong
- & Tianxin Lin
-
Article
| Open AccessPeroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer
- Chui Yan Mah
- , An Dieu Trang Nguyen
- & Lisa M. Butler
-
Article
| Open AccessIntegrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer
- Xiaohe Su
- , Kaifeng Jin
- & Jiejie Xu
-
Review Article
| Open AccessSystemic anticancer therapy for urothelial carcinoma: UK oncologists’ perspective
- Robert J. Jones
- , Simon J. Crabb
- & Syed A. Hussain
-
Article
| Open AccessUrine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation
- Bastiaan J. Viergever
- , Daniëlle A. E. Raats
- & Richard P. Meijer
-
Article |
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)
- Albert Font
- , Begona Mellado
- & Francisco X. Real
-
Article
| Open AccessBody mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts
- Josef Fritz
- , Sylvia H. J. Jochems
- & Tanja Stocks
-
Article |
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)
- Jimmy L. Zhao
- , Emmanuel S. Antonarakis
- & Dana Rathkopf
-
Article
| Open AccessApalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN
- John Shen
- , Simon Chowdhury
- & Julie N. Graff
-
Review Article |
Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility
- Dannielle E. O’Malley
- , Kelsie Raspin
- & Liesel M. FitzGerald
-
Article |
Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsy
- Xiaoshuang Feng
- , Yiwen Zhang
- & Konrad H. Stopsack
-
Article
| Open AccessACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype
- Michelle Shen
- , Shiqin Liu
- & Tanya Stoyanova
-
Article |
Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence
- Ying Hou
- , Ke-Wen Jiang
- & Yu-Dong Zhang
-
Article
| Open AccessLoss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies
- Chloe Gulliver
- , Sebastian Huss
- & Ralf Hoffmann
-
Review Article
| Open AccessFumarate hydratase (FH) and cancer: a paradigm of oncometabolism
- Lorea Valcarcel-Jimenez
- & Christian Frezza
-
Article
| Open AccessExposure to low-level ambient air pollution and the relationship with lung and bladder cancer in older men, in Perth, Western Australia
- Elizabeth H. Lim
- , Peter Franklin
- & Jane Heyworth
-
Article
| Open AccessTargeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
- Josephine A. Hinneh
- , Joanna L. Gillis
- & Lisa M. Butler
-
Article |
A clinically practical model for the preoperative prediction of lymph node metastasis in bladder cancer: a multicohort study
- Junlin Lu
- , Jiajian Lai
- & Tianxin Lin
-
Article
| Open AccessA Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer
- Valentine M. Macaulay
- , Simon Lord
- & Johann de Bono
-
Article
| Open AccessAtopic allergic conditions and prostate cancer risk and survival in the Multiethnic Cohort study
- Anqi Wang
- , Peggy Wan
- & Christopher A. Haiman
-
Article
| Open AccessPamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial
- Michael Friedlander
- , Linda Mileshkin
- & Alexander Spira
-
Article
| Open AccessExposure to benzene and other hydrocarbons and risk of bladder cancer among male offshore petroleum workers
- Nita K. Shala
- , Jo S. Stenehjem
- & Tom K. Grimsrud
-
Review Article |
Immunogenomic profiles associated with response to life-prolonging agents in prostate cancer
- Vincenza Conteduca
- , Nicole Brighi
- & Ugo De Giorgi
-
Article
| Open AccessComputational textural mapping harmonises sampling variation and reveals multidimensional histopathological fingerprints
- Otso Brummer
- , Petri Pölönen
- & Oscar Brück
-
Article |
Insulin receptor expression to predict resistance to axitinib and elucidation of the underlying molecular mechanism in metastatic renal cell carcinoma
- Masayuki Takahashi
- , Kei Daizumoto
- & Hiroomi Kanayama
-
Article
| Open AccessPost-diagnostic health behaviour scores and risk of prostate cancer progression and mortality
- Crystal S. Langlais
- , Rebecca E. Graff
- & June M. Chan
-
Editorial |
Precision medicine for prostate cancer—improved outcome prediction for low-intermediate risk disease using a six-gene copy number alteration classifier
- William Lautert-Dutra
- , Rodolfo Borges dos Reis
- & Jeremy A. Squire
-
Article
| Open AccessThe CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
- Theodora A. Constantin
- , Anabel Varela-Carver
- & Charlotte L. Bevan
-
Article
| Open AccessTemporal trends in cardiovascular burden among patients with prostate cancer receiving androgen deprivation therapy: a population-based cohort study
- Jeffrey Shi Kai Chan
- , Danish Iltaf Satti
- & Chi Fai Ng
-
Article |
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients
- Walead Ebrahimizadeh
- , Karl-Philippe Guérard
- & Jacques Lapointe
-
Article
| Open AccessMBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer
- Amy J. Tibbo
- , Andrew Hartley
- & Imran Ahmad
-
-
Article
| Open AccessThe role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma
- Abhenil Mittal
- , Esmail Al-Ezzi
- & Aaron R. Hansen
-
Article
| Open AccessSelective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling
- Yu-Chieh Tsai
- , Tzu-Yin Wang
- & Sheng-Fang Su
-
Article |
Plasma extracellular vesicle circRNA signature and resistance to abiraterone in metastatic castration-resistant prostate cancer
- Wen Tao
- , Zi-Huan Luo
- & Liao-Yuan Li
-
Article |
Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer
- Jun Li
- , Nan Liu
- & Michael Basler
-
Article |
High-throughput precision MRI assessment with integrated stack-ensemble deep learning can enhance the preoperative prediction of prostate cancer Gleason grade
- Jie Bao
- , Ying Hou
- & Yu-Dong Zhang
-
Article |
Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population
- Jie Lin
- , Darryl Nousome
- & Kangmin Zhu
-
Article |
PI-RADSAI: introducing a new human-in-the-loop AI model for prostate cancer diagnosis based on MRI
- Ruiqi Yu
- , Ke-wen Jiang
- & Yu-Dong Zhang
-
Article
| Open AccessThe Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer
- Charly Blanc
- , Anissa Moktefi
- & Yamina Hamma-Kourbali
-
Article
| Open AccessAssociation between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
- E. Lin
- , Hans Garmo
- & Danielle Crawley
-
Review Article
| Open AccessThe role of PPARγ in prostate cancer development and progression
- Andrew Hartley
- & Imran Ahmad